TPS®
4Pages

TPS® TPAcyk™ UBC® TUBEX® IDL MonoTotal® Provides knowledge to decision.

An earlier insight into tumor change The tumor marker TPS® is a reliable indicator of tumor cell activity particularly useful in patient management for different carcinomas. Compared with conventional tumor mass markers, the activity marker TPS® provides the clinician with earlier signals about the course of the disease. TPS® is particularly useful in treatment monitoring and surveillance of patients with epithelial cell carcinomas e.g. breast, prostate and ovarian cancer. Cytokeratins Most eukaryotic cells have cytoplasmic cytoskeletal structures known as intermediate filaments. The...

“Compared with conventional tumor mass markers, the activity marker TPS® provides the clinician with earlier signals about the course of the disease.” Marie Torstensson Product Manager, IDL Biotech AB TPS® in cancer patient management – clinical utility Performance characteristics are well defined for patients with epithelial cell carcinomas e.g. breast, prostate and ovarian cancer. Breast cancer TPS® has consistently been found to be a good marker for prediction of prognosis and response to therapy. By serial testing, TPS® can be used for therapy control and follow-up of breast cancer...

TPS® – For management of Breast, Prostate and Ovarian cancer FAST FACTS TPS ® • Specifically measures cytokeratin 18 • Clinically proven utility for cancer management • Available in ELISA and IRMA formats • Well-documented for clinical use in patients with breast, prostate and ovarian cancer References: TPS® general 1. Barak V., et al. Clinical utility of cytokeratins as tumor markers. Clin Biochem 2004; 37:529-540 2. Rydlander L., et al. Molecular characterization of a tissue-polypeptide specific antigen epitope and its relationship to human cytokeratin 18. Eur J Biochem. 1996; 241:...